Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Live-Dead Cell Staining Kit: Product Overview
2026-10-09
The APExBIO Live-Dead Cell Staining Kit (SKU K2081) is described as a dual-fluorescent Calcein-AM Propidium Iodide staining product for distinguishing cells with intact versus compromised membranes. No matched research paper was provided, so independent performance, validation, and comparative claims cannot be established.
Veratridine and the Logic of Excitotoxicity
2026-10-09
Veratridine is a voltage-gated sodium channel opener that connects channel inactivation, depolarization, calcium dysregulation, and neuronal injury. This evidence-focused analysis explains what veratridine models can show, what they cannot establish, and why a classic o-agatoxin IVA study remains important for excitotoxicity research.
Quercetin, Hippo Signaling, and Cataract Protection
2026-10-08
A 2025 study links quercetin’s protective effects in cataract models to suppression of Hippo pathway activity, reduced oxidative stress, and improved lens epithelial-cell survival. The evidence is mechanistically suggestive but remains limited to network analysis, mouse models, and injured cell cultures, so its clinical relevance requires further validation.
Veratridine: From Channel Gating to Translation
2026-10-08
A source-grounded perspective on Veratridine as a voltage-gated sodium channel opener, integrating sodium channel dynamics research, excitotoxicity studies, assay strategy, translational limits, and future opportunities.
Locally Produced DENV-1 RT-LAMP: Study Insights
2026-10-07
The 2025 reference study presents a modular recombinant enzyme system and a DENV-1 primer design intended to reduce dependence on imported diagnostic ingredients in resource-limited settings. Its reported analytical evidence includes detection at 10 copies and discrimination of positive and negative reactions through turbidity, but the work remains pre-clinical and does not establish clinical diagnostic performance.
Glabridin–Gold(I) Complex and Antitumor Immunity
2026-10-07
The reference study introduces complex 6d, which combines an N-heterocyclic carbene gold(I) center with glabridin to target both thioredoxin reductase and MAPK-related immunosuppressive signaling. In liver cancer models, the authors report enhanced dendritic-cell maturation, reduced suppressive immune-cell populations, lower PD-L1 expression, and increased granzyme B, while emphasizing that further validation is needed before clinical translation.
BH3-Mimetics and Apoptotic Sensitivity in Glioblastoma
2026-10-06
Koessinger and colleagues found that glioblastoma, including stem-like tumor cells, depends on the anti-apoptotic proteins BCL-xL and MCL-1 and displays increased apoptotic priming. Their study supports a context-dependent strategy in which combined targeting of these survival dependencies produces antitumor activity in preclinical models, while also highlighting the limits of translating findings from GBM models to clinical treatment.
From Multiplexed CRISPR to Translational Evidence
2026-10-06
Multiplexed CRISPR can generate richer biological insight than single-target editing, but its translational value depends on evidence quality, cellular context, and control of unintended structural and stress responses. This thought-leadership article explains how 293T Cells can support early, human-cell feasibility assessments without being mistaken for a disease-relevant or clinical surrogate.
ARB Reprogramming of Armored and Cold Tumors
2026-10-05
Mei et al. identify AGTR1, the target of angiotensin receptor blockers, as a vulnerability in collagen-rich, immune-excluded armored and cold tumors. Their transcriptomic, mechanistic, in vivo, cohort, and meta-analytic evidence supports a model in which ARB-associated suppression of CAF collagen production may improve response to immune checkpoint blockade, while leaving important questions about causality and clinical translation.
GDC-0941: PI3K Inhibition and Evidence Boundaries
2026-10-05
GDC-0941 is a reported PI3K inhibitor with preferential biochemical activity against PI3Kα and PI3Kδ. Its relevance to PI3K/Akt pathway inhibition in liver cancer is mechanistically plausible but remains distinct from direct evidence in the DRD4-driven hepatocellular carcinoma model.
Dimetridazole: From Virulence Biology to Translation
2026-10-04
Dimetridazole is emerging as a research probe for studying quorum sensing, virulence attenuation, and antibiotic potentiation in Pseudomonas aeruginosa. This evidence-led analysis separates reported findings from translational hypotheses and outlines the questions researchers should resolve before treating antivirulence activity as a development opportunity.
Dual Enzyme-Responsive Peptides for Cancer Selectivity
2026-10-03
A 2026 Biomacromolecules study reports a zwitterionic peptide amphiphile that uses sequential matrix metalloproteinase-7 and cathepsin B responses to control intracellular self-assembly. The design achieved a reported cancer selectivity index of 64.1 and tumor regression in an HT-29 xenograft model, while the available evidence remains limited to defined experimental systems rather than clinical application.
Nelfinavir Mesylate at the HIV–Ferroptosis Interface
2026-10-02
Nelfinavir Mesylate is best known as an orally bioavailable HIV-1 protease inhibitor, but recent evidence positions it as a useful pharmacological bridge between viral maturation, DDI2–NFE2L1 proteostasis, and ferroptosis research. This article explains how to validate target engagement, separate antiviral from proteostasis-driven effects, and translate the compound responsibly across research domains.
Fasudil (HA-1077) HCl ROCK Workflows
2026-10-01
Build reproducible ROCK inhibition experiments for proliferation, migration, and apoptosis studies with a practical Fasudil workflow. The guide also shows how recent Hippo-pathway cataract research can improve assay controls without implying an unvalidated ROCK–Hippo mechanism.
Fluorescein Tyramide: From Signal to Spatial Biology
2026-10-01
Fluorescein Tyramide extends tyramide signal amplification from routine staining to spatially resolved neuroscience. This article translates recent oxytocin-circuit findings into practical decisions for IHC, ISH, and quantitative tissue imaging.